We are driven by respect for the bold entrepreneurs who wake up every morning with the same goal as Magnetic – to improve patients’ lives. With more than 25 years of multifaceted experience at large pharmaceutical and diagnostic companies, start-ups, and as investors, we respect the company building process and are here for our founders, every step of the way.

We understand the complex world of healthcare.

With regulatory and market dynamics unique to the sector, we know how to navigate these complexities and understand the entire lifecycle of healthcare – from discovery, to regulatory, through commercialization. During our decades in the industry, we’ve sat in FDA meetings, negotiated business development deals, and have launched and scaled some of the most ground-breaking technologies and companies in the sector.

Portfolio

View Our Portfolio ›
Cellular barcoding company
Machine learning drug discovery platform
Changing the way complex medicines are made and distributed through technology innovation
Improving healthcare for minority patients through technology-based patient engagement solutions
Acquired by SimpleHealth
Safeguarding birth control through technology that addresses its pain points and obstacles
Using AI to rapidly accelerate drug discovery and development for rare genetic diseases

In the News

View All ›
The New York Times Magazine
04.26.22

Can Virtual Reality Help Ease Chronic Pain? (AppliedVR)

Fierce Pharma
02.15.22

Manufacturing National Resilience snares Takeda plasma development and manufacturing deal

Yahoo!
02.09.22

Resilience Subsidiary Ology Bioservices Awarded Contract Worth Up To $250 Million from U.S. Department of Defense for Botulinum Neurotoxin Treatment

Yahoo! Finance
12.14.21

HiberCell to Collaborate with Merck on Phase 2 Clinical Trial of Odetiglucan in Combination with KEYTRUDA® (pembrolizumab) in Patients with Metastatic Breast Cancer

FDA
11.16.21

FDA Authorizes Marketing of Virtual Reality System for Chronic Pain Reduction (AppliedVR)